Dr. Seiwert on Advice With Immunotherapy for Head and Neck Cancer – OncLive
OncLive |
Dr. Seiwert on Advice With Immunotherapy for Head and Neck Cancer
OncLive Tanguy I. Seiwert, MD, assistant professor of Medicine, University of Chicago Medicine, gives advice to community oncologists on administering immunotherapy to patients with head and neck cancer. In general, these PD-1 agents are well tolerated. |
